Our second aim was to test whether a history of TBI—independent of global differences in Aβ- or tau-PET signal—was associated with spatially heterogeneous Aβ- or tau-PET patterns that deviate from the stereotypical Alzheimer’s disease pattern. This evidence concerns the gene MAPT and Alzheimer disease.